Details for Patent: 11,737,983
✉ Email this page to a colleague
Which drugs does patent 11,737,983 protect, and when does it expire?
Patent 11,737,983 protects SINCALIDE and is included in one NDA.
This patent has three patent family members in three countries.
Drugs Protected by US Patent 11,737,983
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Maia Pharms Inc | SINCALIDE | sincalide | POWDER;INTRAVENOUS | 210850-001 | Nov 22, 2022 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | DIAGNOSIS OF PANCREATIC DISORDERS BY STIMULATING PANCREATIC SECRETION IN COMBINATION WITH SECRETIN PRIOR TO OBTAINING A DUODENAL ASPIRATE FOR ANALYSIS | ⤷ Sign Up | ||
| Maia Pharms Inc | SINCALIDE | sincalide | POWDER;INTRAVENOUS | 210850-001 | Nov 22, 2022 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | DIAGNOSIS OF GALL BLADDER DISORDERS BY STIMULATING GALLBLADDER CONTRACTION, AS MAY BE ASSESSED BY VARIOUS METHODS OF DIAGNOSTIC IMAGING, OR TO OBTAIN BY DUODENAL ASPIRATION A SAMPLE OF CONCENTRATED BILE FOR ANALYSIS | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,737,983
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 3073944 | ⤷ Sign Up | |||
| European Patent Office | 3672616 | ⤷ Sign Up | |||
| World Intellectual Property Organization (WIPO) | 2019040904 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
